Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |